Low dose cyclophosphamide: Mechanisms of T cell modulation
Author:
Funder
NHMRC
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference69 articles.
1. Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B 518-ASTA) in experimental tumours of the rat;Arnold;Nature,1958
2. The treatment of advanced ovarian carcinoma with high dose, intravenous cyclophosphamide;Geisler;Gynecol Oncol,1976
3. Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung;Ettinger;Cancer Treat Rep,1978
4. Intermittent high-dose cyclophosphamide with and without prednisolone: a study of the relationships between toxicity, response and survival in metastatic lung cancer;Thatcher;Cancer,1982
5. High dose imtermittent intravenous cyclophosphamide in non-Hodgkin’s lymphomas: long-term patient follow-up;O’Connell;Oncology,1976
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silymarin mitigates toxic effects of cyclophosphamide on testicular tissue and sperm parameters in mice;Reproductive Biology;2024-12
2. Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management;Computers in Biology and Medicine;2024-09
3. Sialic Acids Blockade‐Based Chemo‐Immunotherapy Featuring Cancer Cell Chemosensitivity and Antitumor Immune Response Synergies;Advanced Healthcare Materials;2024-06-28
4. Ginseng-DF ameliorates intestinal mucosal barrier injury and enhances immunity in immunosuppressed mice by regulating MAPK/NF-κB signaling pathways;European Journal of Nutrition;2024-05-15
5. IL3-Driven T Cell–Basophil Crosstalk Enhances Antitumor Immunity;Cancer Immunology Research;2024-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3